REFERENCES
- Breese, P. E., W. J. Burman, S. Goldberg, and S. E. Weis. 2007. Education level, primary language, and comprehension of the informed consent process. Journal of Empirical Research on Human Research Ethics 2(4): 69–79. http://dx.doi.org/10.1525/jer.2007.2.4.69
- Burman, W. J., S. Weis Breese, N. Bock, J. Bernardo, A. Vernon, and the Tuberculosis Trials Consortium. 2003. The effects of local review on informed consent documents from a multicenter clinical trials consortium. Controlled Clinical Trials 24(3): 245–255. http://dx.doi.org/10.1016/S0197-2456(03)00003-5
- Centers for Disease Control and Prevention. 2010. Distinguishing public health research and public health nonresearch. Available at: http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf
- Centers for Disease Control and Prevention. 2013. Tuberculosis—United States, 1993–2010. Morbidity and Mortality Weekly Report 62(suppl. 3): 149–154.
- Chanaud, C. M. 2008. Determination of required content of the informed consent process for human participants in biomedical research conducted in the U.S. A practical tool to assist clinical investigators. Contemporary Clinical Trials 29(4): 501–506. http://dx.doi.org/10.1016/j.cct.2007.11.006
- Corneli, A. L., J. R. Sorenson, M. E. Bentley, et al. 2012. Improving participant understanding of informed consent in an HIV-prevention clinical trial: A comparison of methods. AIDS and Behavior 16(2): 412–421. http://dx.doi.org/10.1007/s10461-011-9977-z
- Crepeau, A. E., B. I. McKinney, M. Fox-Ryvicker, J. Castelli, J. Penna, and E. D. Wang. 2011. Prospective evaluation of patient comprehension of informed consent. Journal of Bone and Joint Surgery 93(19): e114(1–7). http://dx.doi.org/10.2106/JBJS.J.01325
- Dorman, S. E., S. Goldberg, J. E. Stout, et al. 2012. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: Study 29 of the tuberculosis trials consortium. Journal of Infectious Diseases 206(7): 1030–1040. http://dx.doi.org/10.1093/infdis/jis461
- Hill, Z., C. Tawiah-Agyemang, S. Odei-Danso, and B. Kirkwood. 2008. Informed consent in Ghana: What do participants really understand? Journal of Medical Ethics 34(1): 48–53. http://dx.doi.org/10.1136/jme.2006.019059
- Hollander, M., D. A. Wolfe, and E. Chicken. 2013. Nonparametric statistical methods. Hoboken, NJ: John Wiley & Sons.
- Joffe, S., E. F. Cook, P. D. Cleary, J. W. Clark, and J. C. Weeks. 2001. Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet 358(9295): 1772–1777. http://dx.doi.org/10.1016/S0140-6736(01)06805-2
- Kass, N. E., S. Maman, and J. Atkinson. 2005. Motivations, understanding, and voluntariness in international randomized trials. IRB 27(6): 1–8. http://dx.doi.org/10.2307/3563534
- Kiguba, R., P. Kutyabami, S. Kiwuwa, E. Katabira, and N. K. Sewankambo. 2012. Assessing the quality of informed consent in a resource-limited setting: A cross-sectional study. BMC Medical Ethics 13: 21. http://dx.doi.org/10.1186/1472-6939-13-21
- Montalvo, W., and E. Larson. 2014. Participant comprehension of research for which they volunteer: A systematic review. Journal of Nursing Scholarship 46(6): 423–431. http://dx.doi.org/10.1111/jnu.12097
- National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1979. The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html
- Nishimura, A., J. Carey, P. J. Erwin, J. C. Tilburt, M. H. Murad, and J. B. McCormick. 2013. Improving understanding in the research informed consent process: A systematic review of 54 interventions tested in randomized control trials. BMC Medical Ethics 14: 28. http://dx.doi.org/10.1186/1472-6939-14-28
- Sandman, L., A. Mosher, A. Khan, et al. 2006. Quality assurance in a large clinical trials consortium: The experience of the Tuberculosis Trials Consortium. Contemporary Clinical Trials 27(6): 554–560. http://dx.doi.org/10.1016/j.cct.2006.06.003
- U.S. Department of Health and Human Services. 2009. 45 CFR 46 Protection of human subjects. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html.
- U.S. Department of Health and Human Services. 2011a. Federal policy for the protection of human subjects ('Common Rule'). Available at: http://www.hhs.gov/ohrp/humansubjects/commonrule/index.html (accessed February 17, 2011).
- U.S. Department of Health and Human Services. 2011b. Informed consent—FAQs: Who must sign the informed consent or parental permission document? Available at: http://www.hhs.gov/ohrp/policy/faq/informed-consent/who-must-sign-informed-consent-document.html (accessed July 7, 2014).
- U.S. Department of Health and Human Services. 2013. 21 CFR 50 Protection of human subjects. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=50&showFR=1&subpartNode=21:1.0.1.1.20.2
- U.S. Department of Health and Human Services and Office of the Secretary. 2011. Human subjects research protections: Enhancing protections for research subjects and reducing burden, delay, and ambiguity for investigators. Federal Register 76(143): 44512–44531 Available at: http://www.gpo.gov/fdsys/pkg/FR-2011-07-26/pdf/2011-18792.pdf.
- World Health Organization. 2014. Global tuberculosis report 2014. Geneva, Switzerland: World Health Organization.
- Yates, B. C., D. Dodendorf, J. Lane, et al. 2009. Testing an alternate informed consent process. Nursing Research 58(2): 135–139. http://dx.doi.org/10.1097/NNR.0b013e31818c3df5